South Korea · 
Who invested in Mitoimmune Therapeutics?
Mitoimmune Therapeutics's investors include KB Investment, Korea Development Bank, IMM Investment and SL Investment.
South Korea · Venture startup
Who invested in Mitoimmune Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$3.9Mraised across 1 round since 2023, from 1 source
- Latest round
- Venture, $3.9MSept 2023
- Investors
- 4
The rounds
- Sept 2023
Everyone who backed them
SL InvestmentPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mitoimmune Therapeutics
How much has Mitoimmune Therapeutics raised?
Mitoimmune Therapeutics has raised $3.9M across 1 round since 2023.
When did Mitoimmune Therapeutics last raise?
Mitoimmune Therapeutics's most recent round was a Venture of $3.9M in Sept 2023.
What was Mitoimmune Therapeutics's biggest round?
Its most recent round, $3.9M in Sept 2023, is also its largest on record.
Who backed Mitoimmune Therapeutics first?
Mitoimmune Therapeutics's first round on record, in Sept 2023, was backed by KB Investment, Korea Development Bank and IMM Investment and 1 others.
What stage is Mitoimmune Therapeutics at?
Mitoimmune Therapeutics's latest named round is a Venture, in Sept 2023.
Where is Mitoimmune Therapeutics based?
Mitoimmune Therapeutics is based in South Korea.
Companies like Mitoimmune Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.